Patents Examined by Gabriele E. Bugaisky
-
Patent number: 7087407Abstract: The present invention relates to polynucleotide and polypeptide molecules for zamp1, a novel member of the ?-defensin family. The polypeptides, and polynucleotides encoding them, exhibit anti-microbial activity and may be used in the study or treatment of microbial infections. The present invention also includes antibodies to the zamp1 polypeptides.Type: GrantFiled: April 7, 2003Date of Patent: August 8, 2006Assignee: ZymoGenetics, Inc.Inventors: David A. Adler, James L. Holloway, Nand Baindur, Stephanie Beigel-Orme, Paul O. Sheppard
-
Patent number: 7074900Abstract: Thioredoxin, a small dithiol protein, is a specific reductant for allergenic proteins and particularly allergenic proteins present in pollen and animal and plant sources. All targeted proteins contain disulfide (S—S) bonds that are reduced to the sulfhydryl (SH) level by thioredoxin. The proteins are allergenically active and less digestible in the oxidized (S—S) state. When reduced (SH state), they lose their allergenicity and/or become more digestible. Thioredoxin achieved this reduction when activated (reduced) either by NADPH via NADP-thioredoxin reductase (physiological conditions) or by lipoic acid chemical reductant. Skin tests carried out with sensitized dogs showed that treatment of the pollens with reduced thioredoxin prior to injection eliminated or decreased the allergenicity of the pollen. Studies showed increased digestion of the pollen proteins by pepsin following reduction by thioredoxin.Type: GrantFiled: April 23, 2003Date of Patent: July 11, 2006Assignee: The Regents of the University of CaliforniaInventors: Bob B. Buchanan, Gregorio del Val, Rosa M. Lozano, Joshua H. Wong, Boihan C. Yee, Oscar L. Frick
-
Patent number: 7071302Abstract: Described herein are genes shown to be essential for programmed cell death in C. elegans, their encoded products (RNA and polypeptides), antibodies directed against the encoded polypeptides; probes for identifying structurally related genes and bioassays for identifying functionally related cell death genes from various organisms; methods and agents for altering (increasing or decreasing) the activity of the cell death-genes and, thus, of altering cell death; and uses therefor. Specifically, two genes shown to be essential for almost all of the cell deaths which occur in the development of C. elegans, referred to as ced-3 and ced-4, have been cloned, sequenced and characterized.Type: GrantFiled: May 24, 2000Date of Patent: July 4, 2006Assignee: Massachusetts Institute of TechnologyInventors: H. Robert Horvitz, Junying Yuan, Shai Shaham
-
Patent number: 7008783Abstract: Nucleic acid sequences coding for the chondroitinase ABC gene and isolated chondroitinase ABE protein produced in a host cell transformed with a nucleic acid vector directing the expression of a nucleotide sequence coding for chondroitinase ABE protein described. Chondroitinase ABC prepared by chemical synthesis also described. Monoclonal and polyclonal antibodies which are specifically reactive with chondroitinase ABC protein are disclosed. The isolated chondroitinase ABC can be used in methods of treating intervertebral disc replacement, promoting neurite regeneration, and detecting galactosaminoglycans.Type: GrantFiled: June 7, 1995Date of Patent: March 7, 2006Assignee: Maruha CorporationInventors: Nobuyuki Sato, Masahiko Shimada, Hiroshi Oda
-
Patent number: 7005291Abstract: Recombinant organisms are provided comprising genes encoding a glycerol-3-phosphate dehydrogenase and/or a glycerol-3-phosphatase activity useful for the production of glycerol from a variety of carbon substrates. The organisms further contain disruptions in the endogenous genes encoding proteins having glycerol kinase and glycerol dehydrogenase activities.Type: GrantFiled: October 25, 2000Date of Patent: February 28, 2006Assignees: E. I. du Pont de Nemours and Company, Genencor InternationalInventors: Ramesh V. Nair, Mark S. Payne, Donald E. Trimbur, Fernando Valle
-
Patent number: 6987023Abstract: The present invention relates to a nucleic acid segment having a coding region segment encoding enzymatically active Pasturella multocida hyaluronate synthase (PmHAS), and to the use of this nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product. Hyaluronate is also known as hyaluronic acid or hyaluronan. The present invention also relates to the use of the PmHAS in constructing “knock-out” mutant strains of P. multocida for use in vaccinations. The present invention further relates to the use of the PmHAS in diagnostic tests in the field determinations of livestock P. multocida infection.Type: GrantFiled: August 12, 2002Date of Patent: January 17, 2006Assignee: The Board of Regents of the University of OklahomaInventor: Paul DeAngelis
-
Patent number: 6960460Abstract: An isolated esterase gene coding for an esterase capable of causing asymmetric hydrolysis of an organic carboxylic acid ester of a cyclopentenolone of formula I: wherein R1 is hydrogen or methyl, and R2 is C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C1-C4 haloalkyl, a C5-C9 aliphatic hydrocarbon moiety which may be optionally protected on the terminal hydroxyl group thereof, or a C5-C9 fatty acid residue which may be optionally protected on the terminal carboxyl group thereof, to produce the cyclopentenolone of formula I in (R)-form, and hybridizing to the base sequence of SEQ ID NO:1, is useful for the industrially favorable production of optically active cyclopentenolones of formula I which serve as the intermediates of drugs, agricultural chemicals or other active products.Type: GrantFiled: May 17, 2002Date of Patent: November 1, 2005Assignee: Sumitomo Chemical Company, LimitedInventors: Takeshi Ishii, Satoshi Mitsuda
-
Patent number: 6682906Abstract: cDNA molecules coding for GAD65 polypeptide are disclosed. The invention provides cDNA molecules comprising a part of the cDNA sequence of GAD65 which encode at least one epitope for autoantibodies to GAD65. The invention also provides cloning vehicles capable of replication and expression comprising cDNA molecules coding for GAD65. The invention further provides for hosts transformed with a vehicle having a cDNA molecule coding for GAD65. In another embodiment, the invention provides for the detection of autoantibodies to GAD65 using the GAD65 polypeptides coded for by the cDNA molecules of the invention.Type: GrantFiled: September 21, 1990Date of Patent: January 27, 2004Assignee: The Regents of the University of CaliforniaInventors: Allan J. Tobin, Mark G. Erlander, Daniel L. Kaufman
-
Patent number: 6656705Abstract: The present invention relates to novel epidermal protein, sciellin. Sciellin polypeptides comprise an N-terminal domain, a central domain containing sixteen repeats and a C-terminal LIM domain. Sciellin polypeptides may function as precursors of the cornified envelope of keratinizing tissues. Described herein are isolated and antisense nucleic acids molecules, recombinant expression vectors, host cells and non-human transgenic animals containing an insertion or a disruption of the sciellin gene. Diagnostic, screening and therapeutic methods utilizing the compositions of the invention are also provided.Type: GrantFiled: March 26, 1999Date of Patent: December 2, 2003Assignee: The General Hospital CorporationInventors: Howard P. Baden, Pamela Olson, Marie-France Champliaud
-
Patent number: 6599725Abstract: The present invention is drawn to methods and compositions for suppressing cell death in plants. Specifically, novel proteins and genes are provided for use in plant transformation. The proteins and genes are useful for activating disease resistance, enhancing plant cell transformation efficiency, engineering herbicide resistance, genetically targeting cell ablations, and other methods involving the regulation of cell death in plants.Type: GrantFiled: February 2, 2001Date of Patent: July 29, 2003Assignees: Pioneer Hi-Bred International, Inc., Curators of the University of MissouriInventors: Steven P. Briggs, Gurmukh S. Johal, John Gray
-
Patent number: 6583108Abstract: The instant invention provides for proteins, polypeptides, nucleic acid sequences, constructs, expression vectors, host cells, pharmaceutical compositions of, and methods for using human placental bikunin, serine protease inhibitor domains, and fragments thereof.Type: GrantFiled: August 31, 1998Date of Patent: June 24, 2003Assignee: Bayer CorporationInventors: Paul P. Tamburini, Gary Davis, Katherine A. Delaria, Christopher W. Marlor, Daniel K. Muller
-
Patent number: 6538121Abstract: Disclosed are human interleukin-1 &bgr; converting enzyme like apoptosis proteases-3 and 4 and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and antibodies and antagonists against such polypeptides. Also provided are methods of using the polypeptides, for example, as an antitumor agent, and antiviral agent, and antibodies and antagonists against such polypeptides for example, for treating Alzheimer's disease, Parkinson's disease, rheumatoid arthritis and head injury.Type: GrantFiled: November 1, 1994Date of Patent: March 25, 2003Assignee: Human Genome Sciences, Inc.Inventors: Wei Wu He, Craig A. Rosen, Peter L. Hudson, Gregg A. Hastings
-
Patent number: 6495519Abstract: Disclosed are human interleukin-1 &bgr; converting enzyme like apoptosis proteases-3 and 4 and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and antibodies and antagonists against such polypeptides. Also provided are methods of using the polypeptides, for example, as an antitumor agent, and antiviral agent, and antibodies and antagonists against such polypeptides for example, for treating Alzheimer's disease, Parkinson's disease, rheumatoid arthritis and head injury.Type: GrantFiled: July 28, 1998Date of Patent: December 17, 2002Assignee: Human Genome Sciences, Inc.Inventors: Wei Wu He, Craig A. Rosen, Peter L. Hudson, Gregg A. Hastings
-
Patent number: 6306583Abstract: Isolated cDNA clones from human brain (frontal cortex) cDNA libraries that encode a unique subtype of the low Km, cAMP-specific phosphodiesterases (PDE IVs) are disclosed. Analysis of the distribution of hPDE IVB mRNA expression in various human tissues using a nonconserved fragment of the cDNA as a probe revealed a restricted pattern of expression, with an ˜4-kb mRNA detected in brain, heart, lung and skeletal muscle and not in placenta, liver, kidney or pancreas. Furthermore, an additional ˜5-kb hPDE IVB-related mRNA species was detected in brain tissue. Expression of hPDE IVB in a genetically-engineered PDE-deficient strain of the yeast Saccharomym cerevisiae resulted in the overproduction of cAMP PDE activity which displayed the expected kinetic characteristics for a PDE IV: 1) low Km (4.3 &mgr;M) for cAMP, 2) high Km (>3 mM) for cGMP, and 3) sensitivity to rolipram (Ki=0.085 &mgr;M), a selective inhibitor of PDE IV.Type: GrantFiled: May 22, 1995Date of Patent: October 23, 2001Assignee: SmithKline Beecham CorporationInventors: George P. Livi, Megan M. McLaughlin, Theodore J. Torphy
-
Patent number: 6297360Abstract: This invention relates to amphipathic protein-1 polypeptides that can protect plants from tissue damage caused by the hypersensitive response, which is often elicited by bacterial infection in higher plants.Type: GrantFiled: September 3, 1999Date of Patent: October 2, 2001Assignee: Academia SinicaInventors: Teng-yung Feng, Hae-jan Lin
-
Patent number: 6294169Abstract: Human ICE LAP-6 polypeptides and DNA (RNA) encoding such ICE LAP-6 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such ICE LAP-6 for the treatment of a susceptibility to viral infection, tumorogenesis and to diseases and defects in the control embryogenesis and tissue homeostasis, and the nucleic acid sequences described above may be employed in an assay for ascertaining such susceptibility.Type: GrantFiled: April 27, 1999Date of Patent: September 25, 2001Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corporation, University of MichiganInventors: Vishva M. Dixit, Wei-Wu He, Kristine K. Kikly, Steven M. Ruben
-
Patent number: 6291162Abstract: The present invention is directed to nucleic acid molecules that encode a cytosolic form of beta-lactamase and cells that include such nucleic acid molecules. These cells can be used in a variety of methods, such as methods for monitoring the expression of a gene.Type: GrantFiled: October 15, 1996Date of Patent: September 18, 2001Assignee: The Regents of the University of CaliforniaInventors: Roger Y. Tsien, Gregor Zlokarnik
-
Patent number: 6277620Abstract: Topoisomerase III polypeptides and DNA and RNA encoding such Topoisomerase III polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Topoisomerase III for the treatment of infection, particularly bacterial infections. Antagonists against such Topoisomerase III and their use as a therapeutic to treat infections, particularly bacterial infections are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to the presence of Topoisomerase III nucleic acid sequences and the polypeptides in a host. Also disclosed are diagnostic assays for detecting polynucleotides encoding Streptococcal Topoisomerase El and for detecting the polypeptide in a host.Type: GrantFiled: April 26, 1999Date of Patent: August 21, 2001Assignee: SmithKline Beecham CorporationInventors: Michael N. Gwynn, Howard Kallendar
-
Patent number: 6274318Abstract: The invention provides an isolated gene encoding Mch6 as well as functional fragments thereof. Also provided are isolated nucleic acid sequences encoding Mch6 or functional fragments thereof. The gene or nucleic acid sequences can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch6 nucleotide sequences. The invention further provides an isolated Mch6 polypeptide and isolated large and small subunits of the Mch6 polypeptide, including functional fragments thereof.Type: GrantFiled: May 13, 1999Date of Patent: August 14, 2001Assignee: Thomas Jefferson UniversityInventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack
-
Patent number: 6271361Abstract: The invention provides an isolated gene encoding Mch6 as well as functional fragments thereof. Also provided are isolated nucleic acid sequences encoding Mch6 or functional fragments thereof. The gene or nucleic acid sequences can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch6 nucleotide sequences. The invention further provides an isolated Mch6 polypeptide and isolated large and small subunits of the Mch6 polypeptide, including functional fragments thereof.Type: GrantFiled: February 25, 1999Date of Patent: August 7, 2001Assignee: Thomas Jefferson UniversityInventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack